Verywell Health on MSN
How is Huntington's disease diagnosed?
Medically reviewed by Smita Patel, DO Key Takeaways Genetic testing is the definitive diagnostic tool to identify the gene that causes Huntington’s disease, and you can have the genetic test years ...
Experimental gene therapies like AMT‑130 lower toxic huntingtin protein and significantly slow Huntington’s disease, offering ...
Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...
Huntington's disease is caused by an inherited genetic change that causes production of an altered protein. This leads to nerve damage in areas of the brain that control movement and thinking.
Skyhawk Therapeutics has announced positive interim results from its phase 1 trial of SKY-0515, an investigational treatment ...
Verywell Health on MSN
What are the symptoms of Huntington's disease?
Medically reviewed by Smita Patel, DO Key Takeaways Huntington’s disease causes unintentional movements, as well as difficulty walking and controlling movements.Dementia, which is a decline in ...
PTC Therapeutics, Inc. (NASDAQ:PTCT) on Monday announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington’s disease (HD) patients. Huntington’s disease is ...
Treatment with pridopidine slowed clinical progression and maintained function, cognition, and motor performance in pre-defined analyses of a subgroup of early-stage Huntington’s disease (HD) patients ...
UCL and uniQure report the first treatment to slow Huntington’s disease with gene therapy AMT-130. High-dose patients had 75% less progression over three years compared with standard care. uniQure ...
Inc., a clinical-stage biotechnology company developing novel small molecule therapies to modulate critical RNA targets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results